Funding for this research was provided by:
Received: 4 December 2020
Accepted: 9 July 2021
First Online: 28 July 2021
: The study was reviewed and approved by Advarra (formerly Institutional Review Board Services) on 22 January 2016, the University of Victoria on 7 April 2016 (#16–093), and the Alberta Health Research Ethics Board of Alberta 3 October 2016 (HREBA.CHC160019).Tilray was the study sponsor and participated in the design of the study, along with co-investigators from the University of British Columbia and University of Victoria. All data gathering was conducted by health care providers and medical staff in-clinic, and analysis was conducted at arms length by the Centre for Health Evaluation Outcome Sciences at UBC and Broadstreet.
: Not applicable.
: PL was Vice-President, Global Patient Research and Access for Tilray, an authorized. medical cannabis production and research company, during this study. SB has no competing financial interests. MJM has no competing financial interests. He is supported by the United States. National Institutes of Health (U01-DA0251525), a New Investigator Award from the Canadian. Institutes of Health Research (CIHR) and a Scholar Award from the Michael Smith Foundation for Health Research (MSFHR). M-JM is the Canopy Growth professor of cannabis science at the University of British Columbia (UBC), a position created using unstructured arms’ length gifts to the university from Canopy Growth Corporation, a licensed producer of cannabis, and the Government of British Columbia’s Ministry of Mental Health and Addictions. UBC has also received unstructured funding from NG Biomed, Ltd., an applicant to the Canadian federal government for a license to produce cannabis, to support MJM. ZW is the Primary. Investigator in a Tilray-sponsored randomized clinical trial of medical cannabis and PTSD; and has also received research funding from DOJA licensed producer of cannabis; he receives no. financial compensation from Tilray or DOJA. ZW is also a Director of Indigenous. Bloom Corporation which works to establish opportunities for Canadian Indigenous groups to engage in the cannabis industry. He has been compensated for his work with shares in Indigenous Bloom.